There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - Senate

Short Titles as Introduced

Patient Access to ESRD New Innovative Devices Act

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to amend title XVIII of the Social Security Act to improve access to innovative new medical devices furnished to individuals with end stage renal disease under part B of the Medicare program by establishing a new device add-on payment adjustment under such part.


Actions Overview (1)

Date
10/30/2019Introduced in Senate

All Actions (1)

Date
10/30/2019Read twice and referred to the Committee on Finance.
Action By: Senate

Cosponsors (4)

* = Original cosponsor
CosponsorDate Cosponsored
Sen. Sinema, Kyrsten [D-AZ]* 10/30/2019
Sen. Hyde-Smith, Cindy [R-MS]* 10/30/2019
Sen. Jones, Doug [D-AL]* 10/30/2019
Sen. Carper, Thomas R. [D-DE] 01/13/2020

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
Senate Finance10/30/2019 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Subjects (1)


Latest Summary (1)

There is one summary for S.2751. View summaries

Shown Here:
Introduced in Senate (10/30/2019)

Patient Access to ESRD New Innovative Devices Act

This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish a process to provide a certain payment adjustment under the Medicare end-stage renal disease (ESRD) prospective payment system. Specifically, the CMS must establish a process to provide for a temporary add-on payment adjustment for new medical devices used to diagnose, treat, or manage ESRD.